Alaunos Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. NOTABLESCHEDULE 13D/AAlaunos Therapeutics, Inc.TCRT3d

   Alaunos Therapeutics, Inc. files 13D/A

   • Postma Robert W filed 13D/A on 2026-10-15.
   • Issuer has 3,440,670 shares outstanding as of Oct 13, 2026.
   • Repurchase agreement involves $1.6 million for preferred stock.

   Robert W Postma, filed by

2. ROUTINE3Alaunos Therapeutics, Inc.TCRT3d

   Fairmount Healthcare Co-Invest VII L.P. filed Form 3

   • Filed on 2026-10-15
   • Owns 687,789 common shares
   • Holdings include 105,286,000 Series B Preferred Stock

   Peter Evan Harwin, reporting · Fairmount Healthcare Fund II L.P., reporting · +3 more

3. NOTABLESCHEDULE 13DAlaunos Therapeutics, Inc.TCRT3d

   Alaunos Therapeutics, Inc. (TCRT) - Fairmount Funds Management LLC files 13D

   • 858,789 shares of Common Stock held by Reporting Persons
   • Aggregate purchase price of $100,199,073.47
   • 19.99% ownership in Alaunos Therapeutics

   Fairmount Funds Management LLC, filed by

4. ROUTINE8-KAlaunos Therapeutics, Inc.TCRT6d

   Alaunos Therapeutics acquires Velaris

   • Acquired Velaris Therapeutics on 2026-10-13
   • Issued 105,286 Series B Preferred Stock and 33,054 Series C Preferred Stock
   • Agreed to increase Common Stock authorization and change company name
5. MAJOR8-KAlaunos Therapeutics, Inc.TCRTOct 9

   Alaunos Therapeutics faces delisting

   • Received notice of non-compliance with Nasdaq's $2.5M equity rule
   • Scheduled hearing before Nasdaq Hearings Panel
   • Exploring strategic alternatives to regain compliance
6. ROUTINE4Alaunos Therapeutics, Inc.TCRTOct 8

   4 insider filings

   Michael Allen Jerman, insider filing for TCRT

   Show all 4

   • 4Insider filing for TCRTOct 8
   • 4Insider filing for TCRTOct 8
   • 4Insider filing for TCRTOct 8
   • 4Insider filing for TCRTOct 8

   Michael Allen Jerman, reporting

7. ROUTINE8-KAlaunos Therapeutics, Inc.TCRTSep 22

   Current report

8. ROUTINE424B3Alaunos Therapeutics, Inc.TCRTSep 21

   Securities offering

9. ROUTINE8-KAlaunos Therapeutics, Inc.TCRTSep 17

   Current report

10. NOTABLE10-QAlaunos Therapeutics, Inc.TCRTAug 14

    Quarterly report

11. ROUTINE4Alaunos Therapeutics, Inc.TCRTAug 11

    Holger Weis, insider filing for TCRT

    Holger Weis, reporting

12. ROUTINE4Alaunos Therapeutics, Inc.TCRTJul 27

    4 insider filings

    Michael Allen Jerman, insider filing for TCRT

    Show all 4

    • 4Insider filing for TCRTJul 27
    • 4Insider filing for TCRTJul 27
    • 4Insider filing for TCRTJul 27
    • 4Insider filing for TCRTJul 27

    Michael Allen Jerman, reporting

13. ROUTINES-8Alaunos Therapeutics, Inc.TCRTJul 6

    Employee stock plan registration

14. ROUTINE4Alaunos Therapeutics, Inc.TCRTJul 2

    Holger Weis, insider filing for TCRT

    Holger Weis, reporting

15. ROUTINE8-KAlaunos Therapeutics, Inc.TCRTJun 29

    Current report

16. ROUTINE4Alaunos Therapeutics, Inc.TCRTJun 17

    Holger Weis, insider filing for TCRT

    Holger Weis, reporting

17. ROUTINE4Alaunos Therapeutics, Inc.TCRTMay 27

    Holger Weis, insider filing for TCRT

    Holger Weis, reporting

18. ROUTINE8-KAlaunos Therapeutics, Inc.TCRTMay 26

    Current report

19. ROUTINE8-KAlaunos Therapeutics, Inc.TCRTMay 18

    Current report

20. NOTABLE10-QAlaunos Therapeutics, Inc.TCRTMay 15

    Quarterly report

21. ROUTINE4Alaunos Therapeutics, Inc.TCRTMay 1

    3 insider filings

    Jaime Vieser, insider filing for TCRT

    Show all 3

    • 4Insider filing for TCRTMay 1
    • 4Insider filing for TCRTMay 1
    • 4Insider filing for TCRTMay 1

    Jaime Vieser, reporting

22. ROUTINE10-K/AAlaunos Therapeutics, Inc.TCRTApr 30

    Annual report (amended)

23. ROUTINE8-KAlaunos Therapeutics, Inc.TCRTApr 15

    Current report

24. NOTABLE10-KAlaunos Therapeutics, Inc.TCRTMar 31

    Annual report

25. NOTABLESCHEDULE 13D/AAlaunos Therapeutics, Inc.TCRTMar 5

    Ownership stake disclosure by Adrian Price (amended)

    Adrian Price, filed by

26. ROUTINE8-KAlaunos Therapeutics, Inc.TCRTMar 2

    Current report

27. NOTABLESCHEDULE 13D/AAlaunos Therapeutics, Inc.TCRTFeb 24

    Ownership stake disclosure by Adrian Price (amended)

    Adrian Price, filed by

28. ROUTINE4Alaunos Therapeutics, Inc.TCRTJan 15

    3 insider filings

    Jaime Vieser, insider filing for TCRT

    Show all 3

    • 4Insider filing for TCRTJan 15
    • 4Insider filing for TCRTJan 15
    • 4Insider filing for TCRTJan 15

    Jaime Vieser, reporting

29. ROUTINE8-KAlaunos Therapeutics, Inc.TCRTJan 8

    Current report

30. ROUTINE8-KAlaunos Therapeutics, Inc.TCRTDec 23, 2025

    Current report

31. ROUTINE424B8Alaunos Therapeutics, Inc.TCRTDec 11, 2025

    Securities offering

32. NOTABLESCHEDULE 13D/AAlaunos Therapeutics, Inc.TCRTDec 5, 2025

    Ownership stake disclosure by Adrian Price (amended)

    Adrian Price, filed by

33. ROUTINE4Alaunos Therapeutics, Inc.TCRTNov 26, 2025

    3 insider filings

    Jaime Vieser, insider filing for TCRT

    Show all 3

    • 4Insider filing for TCRTNov 26, 2025
    • 4Insider filing for TCRTNov 26, 2025
    • 4Insider filing for TCRTNov 26, 2025

    Jaime Vieser, reporting

34. NOTABLE10-QAlaunos Therapeutics, Inc.TCRTNov 14, 2025

    Quarterly report

35. ROUTINES-3/AAlaunos Therapeutics, Inc.TCRTNov 7, 2025

    Securities offering (amended)

36. NOTABLESCHEDULE 13D/AAlaunos Therapeutics, Inc.Oct 31, 2025

    Ownership stake disclosure by Adrian Price (amended)

    Adrian Price, filed by

37. NOTABLESCHEDULE 13DAlaunos Therapeutics, Inc.Oct 30, 2025

    Ownership stake disclosure by Adrian Price

    Adrian Price, filed by

Older filings on EDGAR